Wells Fargo & Company Horizon Therapeutics Public LTD CO Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$98.98 - $115.74 $1.03 Million - $1.2 Million	-10,385 Reduced 19.16%	43,803 $5.07 Million
Q2 2023 Aug 15, 2023	SELL	$96.34 - $112.38 $22 Million - $25.7 Million	-228,778 Reduced 80.85%	54,188 $5.57 Million
Q1 2023 May 12, 2023	BUY	$107.32 - $113.5 $14 Million - $14.8 Million	130,345 Added 85.4%	282,966 $30.9 Million
Q4 2022 Feb 13, 2023	SELL	$62.39 - $113.8 $3.49 Million - $6.37 Million	-55,977 Reduced 26.83%	152,621 $17.4 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $4.3 Million - $6.18 Million	-72,990 Reduced 25.92%	208,598 $12.9 Million

Q2 2022 Aug 12, 2022	SELL	$79.4 - $116.36 $7.48 Million - $11 Million	-94,207 Reduced 25.07%	281,588 $22.5 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $414,556 - $526,758	-4,797 Reduced 1.26%	375,795 $39.5 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $148 Million - $180 Million	-1,499,821 Reduced 79.76%	380,592 $41 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $35.7 Million - $42.8 Million	387,995 Added 26.0%	1,880,413 $206 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $12.4 Million - $13.8 Million	144,289 Added 10.7%	1,492,418 $140 Million
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $4.52 Million - $6.01 Million	-62,987 Reduced 4.46%	1,348,129 $124 Million
Q4 2020 Feb 09, 2021	BUY	$67.0 - $84.39 $31.2 Million - $39.3 Million	465,229 Added 49.18%	1,411,116 $103 Million
Q3 2020 Nov 05, 2020	BUY	$55.23 - $79.93 $21.6 Million - $31.2 Million	390,965 Added 70.45%	945,887 $73.5 Million
Q2 2020 Aug 13, 2020	BUY	$30.2 - $56.98 $7 Million - $13.2 Million	231,846 Added 71.76%	554,922 $30.8 Million
Q1 2020 May 14, 2020	BUY	$24.87 - $38.56 $8.03 Million - $12.5 Million	323,076 New	323,076 $9.57 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account